Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
Three months after its move to revoke a closure notices issued against 12 highly polluting pharma companies in the city, the Andhra Pradesh Pollution Control Board (APPCB) has now gone a step ahead and is most likely to lift a 15-year-old ban on expansion of bulk drug units in the …
Accepts GoM's final recommendations without changes, say sources The Cabinet today endorsed the recommendations of a Group of Ministers’ (GoM) on a revised National Pharmaceutical Pricing Policy, giving shape to a long-pending issue. The government did not give out details of the decision. According to sources, the Cabinet has imposed …
Europe is set to quash a precedent-setting initiative designed to tackle a disturbing side effect of common drugs — their impact on aquatic life. Nature has learned that landmark regulations intended to clean Europe’s waterways of pharmaceuticals are likely to be dead on arrival when they reach a key vote …
The Central Government on Wednesday said it had resolved all issues concerning the drug pricing policy and would finalise its stand before November 27, the deadline set by the Supreme Court. A Group of Ministers (GoM) headed by Agriculture Minister Sharad Pawar on Wednesday met to discuss the issues. “We …
Chidambaram to be special invitee at Friday?s review meeting SC wants clear policy by November 27 hearing The long-pending pharmaceutical pricing policy revamp, awaiting Cabinet approval, has been sent back to the group of ministers (GoM) which finalised it. The prime minister’s office (PMO) wants the GoM to address concerns …
In a big relief to generic drug major Cipla, the Supreme Court has stayed the Delhi High Court’s order that restrained the Indian company from marketing generic version of its anti-cancer drug Sunitinib, which is being developed by US pharmaceutical firms Sugen and Pharmacia & Upjohn Company. The Indian drug …
New Delhi In a big relief to generic drug major Cipla, the Supreme Court has stayed the Delhi High Court’s order that restrained the Indian company from marketing generic version of its anti-cancer drug Sunitinib, which is being developed by US pharmaceutical firms Sugen and Pharmacia & Upjohn Company. The …
LUCKNOW: Central Drug Research Institute, Lucknow has developed a drug - 'Novel Bone Anabolic Agents' for accelerated healing of fractures by stimulating bone formation. The institute has also recently entered into an exclusive licence agreement with an US-based firm for further production and development. These naturally occurring anabolic agents were …
The increasing demand of the herbal industry for ‘naag chhatri’, a perennial medicinal plant found in the temperate zone of the Himalayas, is leading to its indiscriminate and excessive exploitation and posing a serious threat to it. The herb is being smuggled out of the state in bulk. Over the …
Batches of the world’s first vaccine against the hepatitis E virus began rolling out of a Chinese factory, promising to stem a disease that every year infects about 20 million people and claims 70,000 lives. The vaccine is being hailed as a victory for an unusual public–private partnership that could …
New Delhi: The ban on doctors, being sponsored by pharma firms to attend conferences, could soon get diluted. The department of pharmaceuticals that is preparing the “Uniform Code of Pharmaceutical Marketing Practices” has asked the Union health ministry to take a relook at the existing rule of such activities by …
New Delhi The laxness in branding medicines, a common practice for long but with serious implications for public health besides being an unhealthy business practice, might soon end. A recent health ministry move to bar state drug regulators from granting manufacturing licences on brand names may force companies to queue …
Mumbai Stung by widespread criticism of alleged lax standards in conducting clinical trials in the country, clinical research organisations (CROs), which conduct human drug trials on behalf of pharma companies, have resorted to technology to make the process more transparent. For the first time in India, some CROs and a …
Govt move aimed at making drugs affordable, tackling issues of trademark violations The lobby group Indian Drugs Manufacturing Association will take a call on legal action in its meeting on Friday after a new directive by the health minister banned firms from using brand names while applying for a manufacturing …
The secrecy that has long surrounded drug-industry trials is crumbling. Scientists are applauding drug giant GlaxoSmithKline (GSK) for its announcement last week that it will make the trove of detailed raw data underlying its clinical trials systematically available to researchers. And GSK’s move — the first such commitment for a …
New Delhi The government has decided to stick to the new market-based formula for essential drugs. The formula was proposed by a group of ministers (GoM) headed by Sharad Pawar in the last week of September to fix prices of 348 drugs in the National List of Essential Medicines. The …
Players with integration between clinical work and data are going to dominate the post-BPO scene Regulators round the world have become increasingly concerned about pharmacovigilance, the post-marketing surveillance of a drug for its entire life. Quintiles is offering this service to customers across the globe. About 500 of Quintiles’s staff …
The government on Thursday told the Supreme Court that it would firm up a drug policy by November 27, 2012, and then revise its essential drugs list under the Drug Price Control order to include 348 drugs. The existing essential drugs list has only 74 drugs. “The Cabinet will finalise …
The Supreme Court on Thursday gave one month’s time to the Centre to come up with the final version of the drug pricing policy. Maintaining that the Centre must follow a pricing formula that will prevent the prices of the drugs from shooting up, the SC agreed to wait till …
‘Poverty Line Fixed At 32, But Antibiotics Priced At About 60’ New Delhi: The Centre on Thursday promised to notify a new drug pricing mechanism for essential medicines by the end of November, but the Supreme Court said a change in policy must not force a sharp rise in drug …
